Ngā hua rapu - Kengo Furuichi
- E whakaatu ana i te 1 - 20 hua o te 31
- Haere ki te Whārangi Whai Ake
-
1
-
2
Nonproteinuric diabetic kidney disease mā Masayuki Yamanouchi, Kengo Furuichi, Junichi Hoshino, Yoshifumi Ubara, Takashi Wada
I whakaputaina 2020Revisão -
3
-
4
-
5
The Impacts of Albuminuria and Low eGFR on the Risk of Cardiovascular Death, All-Cause Mortality, and Renal Events in Diabetic Patients: Meta-Analysis mā Tadashi Toyama, Kengo Furuichi, Toshiharu Ninomiya, Miho Shimizu, Akinori Hara, Yasunori Iwata, Shuichi Kaneko, Takashi Wada
I whakaputaina 2013Revisão -
6
-
7
Retinopathy progression and the risk of end-stage kidney disease: results from a longitudinal Japanese cohort of 232 patients with type 2 diabetes and biopsy-proven diabetic kidney... mā Masayuki Yamanouchi, Mikiro Mori, Junichi Hoshino, Keiichi Kinowaki, Takeshi Fujii, Kenichi Ohashi, Kengo Furuichi, Takashi Wada, Yoshifumi Ubara
I whakaputaina 2019Artigo -
8
Blockade of a Chemokine, CCL2, Reduces Chronic Colitis-Associated Carcinogenesis in Mice mā Boryana Konstantinova Popivanova, Feodora Ivanova Kostadinova, Kengo Furuichi, Mohamed M. Shamekh, Toshikazu Kondo, Takashi Wada, Kensuke Egashira, Naofumi Mukaida
I whakaputaina 2009Artigo -
9
Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis mā Akinori Hara, Takashi Wada, Kengo Furuichi, Norihiko Sakai, Hiroshi Kawachi, F Shimizu, M. Shibuya, Kouji Matsushima, Hitoshi Yokoyama, K Egashira, Shuichi Kaneko
I whakaputaina 2006Artigo -
10
Blockade of CCR2 Ameliorates Progressive Fibrosis in Kidney mā Kiyoki Kitagawa, Takashi Wada, Kengo Furuichi, Hiroyuki Hashimoto, Yoshiro Ishiwata, Masahide Asano, Motohiro Takeya, William A. Kuziel, Kouji Matsushima, Naofumi Mukaida, Hitoshi Yokoyama
I whakaputaina 2004Artigo -
11
Gene Therapy Expressing Amino-Terminal Truncated Monocyte Chemoattractant Protein-1 Prevents Renal Ischemia-Reperfusion Injury mā Kengo Furuichi, Takashi Wada, Yasunori Iwata, Kiyoki Kitagawa, K. Kobayashi, Hiroyuki Hashimoto, Yoshiro Ishiwata, Naohisa Tomosugi, Naofumi Mukaida, Kouji Matsushima, Kensuke Egashira, Hitoshi Yokoyama
I whakaputaina 2003Artigo -
12
Association of PAX2 and Other Gene Mutations with the Clinical Manifestations of Renal Coloboma Syndrome mā Toshiya Okumura, Kengo Furuichi, Tomomi Higashide, Mayumi Sakurai, Shinichi Hashimoto, Yasuyuki Shinozaki, Akinori Hara, Yasunori Iwata, Norihiko Sakai, Kazuhisa Sugiyama, Shuichi Kaneko, Takashi Wada
I whakaputaina 2015Artigo -
13
Adipose tissue derived stromal stem cell therapy in murine <scp>C</scp>on<scp>A</scp>‐derived hepatitis is dependent on myeloid‐lineage and <scp>CD</scp>4<sup>+</sup><scp>T</scp>‐c... mā Mami Higashimoto, Yoshio Sakai, Masayuki Takamura, Soichiro Usui, Alessandro Nasti, Keiko Yoshida, Akihiro Seki, Takuya Komura, Masao Honda, Takashi Wada, Kengo Furuichi, Takahiro Ochiya, Shuichi Kaneko
I whakaputaina 2013Artigo -
14
The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese mā Hitoshi Yokoyama, Takashi Wada, Akinori Hara, Junya Yamahana, Izaya Nakaya, Motoo Kobayashi, Kiyoki Kitagawa, Satoshi Kokubo, Yasunori Iwata, Keiichi Yoshimoto, Kazuaki Shimizu, Norihiko Sakai, Kengo Furuichi
I whakaputaina 2004Artigo -
15
Long-Term Outcomes of Japanese Type 2 Diabetic Patients With Biopsy-Proven Diabetic Nephropathy mā Miho Shimizu, Kengo Furuichi, Tadashi Toyama, Shinji Kitajima, Akinori Hara, Kiyoki Kitagawa, Yasunori Iwata, Norihiko Sakai, Toshinari Takamura, Mitsuhiro Yoshimura, Hitoshi Yokoyama, Shuichi Kaneko, Takashi Wada
I whakaputaina 2013Artigo -
16
MIP-1α and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis mā Takashi Wada, Kengo Furuichi, Chikako Segawa‐Takaeda, Miho Shimizu, Norihiko Sakai, Shin‐ichi Takeda, Kazuya Takasawa, Hiroshi Kida, K. Kobayashi, Naofumi Mukaida, Yasukazu Ohmoto, Kouji Matsushima, Hitoshi Yokoyama
I whakaputaina 1999Artigo -
17
Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis mā Takashi Iwakiri, Shouichi Fujimoto, Kiyoki Kitagawa, Kengo Furuichi, Junya Yamahana, Yunosuke Matsuura, Atsushi Yamashita, Shigehiro Uezono, Yoshiya Shimao, Shuichi Hisanaga, Takeshi Tokura, Takashi Wada, Kazuo Kitamura, Yujiro Asada
I whakaputaina 2013Artigo -
18
Gene Therapy via Blockade of Monocyte Chemoattractant Protein-1 for Renal Fibrosis mā Takashi Wada, Kengo Furuichi, Norihiko Sakai, Yasunori Iwata, Kiyoki Kitagawa, Yuko Ishida, Toshikazu Kondo, Hiroyuki Hashimoto, Yoshiro Ishiwata, Naofumi Mukaida, Naohisa Tomosugi, Kouji Matsushima, Kensuke Egashira, Hitoshi Yokoyama
I whakaputaina 2004Artigo -
19
Adipose tissue-derived stem cells as a regenerative therapy for a mouse steatohepatitis-induced cirrhosis model mā Akihiro Seki, Yoshio Sakai, Takuya Komura, Alessandro Nasti, Keiko Yoshida, Mami Higashimoto, Masao Honda, Soichiro Usui, Masayuki Takamura, Toshinari Takamura, Takahiro Ochiya, Kengo Furuichi, Takashi Wada, Shuichi Kaneko
I whakaputaina 2013Artigo -
20
p38 MAPK phosphorylation and NF-kappaB activation in human crescentic glomerulonephritis mā Norihiko Sakai, Takashi Wada, Kengo Furuichi, Yasunori Iwata, Keiichi Yoshimoto, Kiyoki Kitagawa, Satoshi Kokubo, Motoo Kobayashi, Shin‐ichi Takeda, Hiroshi Kida, K. Kobayashi, Naofumi Mukaida, Kouji Matsushima, Hitoshi Yokoyama
I whakaputaina 2002Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Kidney
Endocrinology
Biology
Chemokine
Pathology
Immunology
Inflammation
Diabetes mellitus
Disease
Cancer research
Chemokine receptor
Kidney disease
Biochemistry
Renal function
Monocyte
Proteinuria
CCR2
Cell biology
Chemistry
Fibrosis
Gene
Receptor
Type 2 diabetes
Albuminuria
Gastroenterology
Glomerulonephritis
Ischemia
Nephrology